Lizhu Lin

KLF16-induced Increase of GARS Promotes Glycolysis in Hepatocellular Carcinoma by Stabilizing FOXK1

Prediction of the effect of Bupleurum chinensis DC. (Chaihu) on survival and its potential targets in hepatocellular carcinoma based on a prognostic model

Retraction Note: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis

Negative association of C-reactive protein-albumin-lymphocyte index (CALLY index) with all-cause and cause-specific mortality in patients with cancer: results from NHANES 1999–2018

Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study

Guidelines for the clinical application of the <i>Xihuang</i> pill for the prevention and treatment of breast hyperplasia diseases

61P First-line camrelizumab (Camre) plus carboplatin (Carbo) and pemetrexed (Pem) for advanced non-squamous NSCLC: 5-yr outcomes of CameL phase III study

Corrigendum to “β-Asarone suppresses Wnt/β-catenin signaling to reduce viability, inhibit migration/invasion/adhesion and induce mitochondria-related apoptosis in lung cancer cells” [Biomed. Pharmacother. 106 (2018) 821–830]

Diastolic dysfunction and risks of heart failure and death in long-term adult cancer survivors

Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial

Expert consensus on treatment for stage III non‐small cell lung cancer

Deciphering the Molecular Mechanism of Yifei-Sanjie Pill in Cancer-Related Fatigue

Retraction Note: Weipiling ameliorates gastric precancerous lesions in Atp4a−/− mice

Efficacy and Safety of RC48 in Treating HER2 Advanced Gallbladder Cancer: Case Report and Literature Review

First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis

Inhibitory Effect of Poly(lactic-co-glycolic acid) Nanoparticles Loaded with Resveratrol and Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN) siRNA on Lung Cancer Cells

Zhengyuan capsules for the treatment of chemotherapy-induced cancer-related fatigue in stage IIIB–IV unresectable NSCLC: study protocol for a randomized, multi-center, double-blind, placebo-controlled clinical trial

Fatigue like behavior in different tumor-bearing mice metastasis model for the study of colorectal cancer

Cordycepin Reverses Cisplatin Resistance in Non-small Cell Lung Cancer by Activating AMPK and Inhibiting AKT Signaling Pathway

Adjuvant EGFR-TKIs for Patients With Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis of 1,283 Patients

RETRACTED ARTICLE: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis

Database mining and animal experiment-based validation of the efficacy and mechanism of Radix Astragali (Huangqi) and Rhizoma Atractylodis Macrocephalae (Baizhu) as core drugs of Traditional Chinese medicine in cancer-related fatigue

Network Pharmacology/Metabolomics‐Based Validation of AMPK and PI3K/AKT Signaling Pathway as a Central Role of Shengqi Fuzheng Injection Regulation of Mitochondrial Dysfunction in Cancer‐Related Fatigue

Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review

Multicenter, randomized, double-blind, controlled trial of transcutaneous electrical nerve stimulation for pancreatic cancer related pain

Ginsenoside Rg3 Promotes Cell Growth Through Activation of mTORC1

The impact of surgery on long-term survival of patients with primary intestinal non-Hodgkin lymphomas based on SEER database

P79.02 Updated OS and Time to Second Progression with First-Line Camrelizumab Plus Chemo vs Chemo for Advanced Non-Squamous NSCLC

Analysis of prescription regularity of traditional Chinese medicine for colorectal cancer based on data mining

Mechanism of Hypoxia-Activated MiR-194 /FoxO3a Inducing Glycolytic Metabolism Reprogramming in Gastric Precancerous Lesions